📢 Announcing an innovative new assay for mild traumatic brain injuries (mTBIs)!

The VIDAS® TBI (GFAP, UCH-L1), newly FDA cleared, can help clinicians perform fast, efficient triage for mTBI with confidence. 🧠

Learn more: bit.ly/4bU54hR

Time is a critical factor when you're trying to diagnose a bloodstream infection. ⏱
Traditional testing can take up to 3 days to receive results, but the BIOFIRE® Blood Culture Identification 2 Panel can test for 43 targets in about one hour!
Learn more: biofiredx.com/products/the-f…

Take a behind-the-scenes look at our Immunoassay R&D teams! 👀 At our Marcy-l'Etoile site, over 150 researchers work to create innovative new solutions—in the past 30 years, they have developed over 100 new tests and biomarkers. 💡 #PioneeringDiagnostics bit.ly/4aFfZvp

When you’re testing for pregnancy in an emergency evaluation, speed and accuracy are essential. 
The VIDAS® hCG assay is an easy-to-use test that delivers results you can trust in about 30 minutes.
Learn more about today: go.biomerieux.com/nine-weeks-of-… 

#NineWeeksofVIDAS

Don’t miss your chance to discover the BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel at #DDW2024 ! This syndromic solution can identify 22 targets in one test with results in about one hour.

Come find us in booth 1928 for a live demo! go.biomerieux.com/tradeshows/ddw…

Join us on Thursday, May 30 at 2 PM ET for a webinar with Shawn MacVane, PharmD to learn about the difference that rapid diagnostics can make on antimicrobial stewardship efforts! 💊

👉 Register for free at learn.sepsis.org/products/biome…

If you're at #DDW2024 you won't want to miss our demos of the BIOFIRE® FILMARRAY® TORCH System in booth 1928. This multiplex PCR solution can help you test for 22 GI pathogens in about one hour with just one on-site test.

Find us on the event map: 👉 go.biomerieux.com/tradeshows/ddw…

Healthcare workers will need to work together to preserve the efficacy of antibiotics at every step of the patient journey.

Catherine Duggan, CEO of the International Pharmaceutical Federation, shares the important role that pharmacists play: biomerieux.com/corp/en/blog/a…

Research shows that Black women hospitalized with a blood infection resistant to last-resort antibiotics face an increased risk of death. We must confront the intersectional disparities exacerbating AMR and find solutions to ensure #equitablehealthcare . eurekalert.org/news-releases/…

'Years ago, we tried to put all of those instruments directly into our LIS. It was disastrous… Now we have all that data in one place in MAESTRIA™.' Learn more about this exciting new microbiology middleware from the BIOMÉRIEUX VISION SUITE: bit.ly/3PloZNA

🔎 Recent findings from a U.S. study: Antimicrobial-resistant hospital infections persist at levels at least 12% above pre-pandemic rates.

#OptimizeDiagnostics #OptimizeTherapy
With our complete solution for #AMS .

Learn more: eurekalert.org/news-releases/…

“AMR is a complex challenge that requires a collaborative One Health approach.” – Alexandre Mérieux, Chairman of the Board of Directors, bioMérieux

Yesterday bioMérieux & @FranceintheUS held a joint conference, “Rising to the Challenge: United Against #AntimicrobialResistance .”

Have you heard of our prenatal care assay menu? Get the full picture on toxoplasmosis and cytomegalovirus with the VIDAS® TOXO IgM, VIDAS® TOXO IgG, VIDAS® CMV IgM, and VIDAS® CMV IgG!

Unlock the full VIDAS® 3 immunoassay menu today: bit.ly/3yt5Svu #NineWeeksofVIDAS

📝Sign the ReAct - Action on Antibiotic Resistance campaign 'From People to Leaders: Act on AMR NOW' ahead of the United Nations #AMR meeting. This movement promotes responsible antibiotic use and advocates for sustainable solutions to address AMR - including optimized #diagnostics . bit.ly/3WIkCRy

🔬 Researchers found that the use of rapid #diagnostic tests and #antimicrobialstewardship programs (ASP) may lead to patient survival benefit - even in settings already adopting an effective #ASP in association with conventional blood cultures. Read more: bit.ly/3JZaGeF

🔍 Check out this comprehensive overview of #AMR surveillance and data flow in the U.S. The ASHE Journal article provides insights into navigating the network of AMR surveillance, a crucial aspect of healthcare management, co-authored by our experts! bit.ly/3UWAOgJ

The future of respiratory diagnostics is here! 🎉

With the ability to test to up to 15 targets, BIOFIRE® SPOTFIRE® has the flexibility to let you choose what's right for your patient.

Learn more or request a demo today 👉 bit.ly/3QCl93o

🩺 Did you know #sepsis is the leading cause of death of young children and babies worldwide? Diagnostics play a pivotal role in preventing sepsis. Learn more about the signs and symptoms here: bit.ly/3UQ7YhI

H. pylori can have far-reaching effects on patient health and early diagnosis can help prevent the worst of them.

Meet VIDAS® H. pylori, a non-invasive test with only 35 minutes to result! Unlock the full VIDAS 3 assay menu today: bit.ly/3ycT4cM #NineWeeksofVIDAS

Syndromic testing gives you the information you need to make informed diagnostic decisions during patient visits, even when symptoms are overlapping or unclear.

Want to learn how #syndromictesting can transform your practice? Download our full guide 👉 bit.ly/44xhpWC